Deferoxamine, CAS [[70-51-9]]

Product Overview

• Article Name: Deferoxamine, CAS [[70-51-9]]
• Biozol Catalog Number: MCE-HY-B1625
• Supplier Catalog Number: HY-B1625
• Alternative Catalog Number: MCE-HY-B1625-100MG,MCE-HY-B1625-5MG,MCE-HY-B1625-50MG,MCE-HY-B1625-1MG,MCE-HY-B1625-10MMX1ML,MCE-HY-B1625-10MG,MCE-HY-B1625-25MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: Deferoxamine B, Deferriferrioxamine B, Deferrioxamine

Product Description

Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1alpha levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

Product Properties

• Molecular Weight: 560.68
• Purity: 99.76
• CAS Number: [70-51-9]
• Formula: C25H48N6O8
• Target: Akt,Apoptosis,Autophagy,HIF/HIF Prolyl-Hydroxylase,Reactive Oxygen Species (ROS)

Application Notes

• Application Notes: MCE Product type: Reference compound